Xeltis completes enrollment for ETG technology trial. By Omar Ford, MDD Staff Writer. Xeltis was the lead front page story for the distinguished industry publication Medical Device Daily on 4 March 2014. The article starts with: ‘ What if there was an application that could ensure the process of natural tissue growth from within the body, eliminating the use of external stem cells or animal-derived products? Such a treatment could overcome the limitations of the current standard of care and quite possibly reduce long-term medication and the risk of repeated surgeries…’ The article continues on. If you are not already subscribed to MDD, the daily medical technology news source, you can do so via here. Click for the full article.